Novartis Bone Drug Suit Falls Under NJ Damages Law: Court

Law360, New York (November 18, 2011, 6:39 PM EST) -- A New Jersey state court ruled Friday that New Jersey punitive damages law applies in a product liability case against Novartis Pharmaceutical Corp. over the bone drug Zometa, a decision that could exclude punitive damages in the case.

The plaintiff, Charles Irby of Virginia, claims that Zometa caused him to develop osteonecrosis — also known as “bone death” — of the jaw. Novartis has been fighting hundreds of similar cases over Zometa and another medication, Aredia, in state and federal courts.

Although both sides agreed that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.